跳至主要内容
临床试验/CTRI/2021/04/033079
CTRI/2021/04/033079尚未招募3 期

Efficacy of Shallakyadi Capsule in the management of Post Chikungunya Chronic Inflammatory Rheumatism- a single arm open labelled clinical study

Institute of Teaching and Research in Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Confirm case of Chikungunya fever with symptoms of pCHIK-CIR
  • Patient willing to participate in the trial

排除标准

  • Age below 18 years & above 60 years.
  • Pregnant and lactating women
  • History of RA, Gout, Psoriatic arthritis, rheumatic fever, autoimmune disease, thyroid dysfunction, sarcoidosis, SLE before Chikungunya fever.
  • Patients suffering from: Malignant and accelerated hypertension, coronary artery disease, uncontrolled diabetes.
  • Patient undergoing regular treatment for any other severe illness and also patients suffering from pulmonary tuberculosis or bone tuberculosis, carcinoma and HIV positive patients.

研究者

发起方
Institute of Teaching and Research in Ayurveda

相似试验